News – Page 128 – Endpoints News

Indivior reaches $86M settlement over its alleged role in the opioid epidemic

10 months ago

Roivant's dealmaker lands $81M cash bonus following drug sale to Roche

10 months ago

Pfizer cuts 210 North Carolina workers after it officially discontinues failed Duchenne gene therapy

10 months ago

FDA's ad enforcer critiques Brittany Mahomes' paid Instagram post for Kaléo

10 months ago

Boehringer Ingelheim buys oncology biotech for up to $1.3B

10 months ago

Ventyx axes development of TYK2 inhibitor following Phase 2 failure

10 months ago

Cognition Therapeutics' stock sinks on Phase 2 Alzheimer’s data

10 months ago

Collegium pays $525M to buy ADHD company; FDA delays Syndax decision

10 months ago

NewAmsterdam succeeds in the first of three key pivotal studies, providing hope to a troubled cardio class

10 months ago

WuXi AppTec sees US revenue decline amid Biosecure threat

10 months ago

Updated: GSK and Flagship to create up to 10 vaccines, medicines across respiratory and immunology

10 months ago

AstraZeneca’s fixed-duration Calquence combo succeeds in Phase 3 blood cancer test

10 months ago

vTv Therapeutics' diabetes drug program hit with clinical hold from FDA

10 months ago

Anavex’s new analysis of its Alzheimer’s pill shows mixed results

10 months ago

Mapping GLP-1 game plans; Q2 earnings highlights; J&J vets regroup at startup; and more

10 months ago

Compounded weight loss drugs have resulted in misdosing, hospitalizations, FDA warns

10 months ago

Among pharma CEOs, the IRA now and the IRA later get very different reactions

10 months ago

Pfizer and BioNTech say GSK's Covid patent suit is 'groundless'

10 months ago

Updated: Bristol Myers restarts radiopharmaceutical Phase 3 trial

10 months ago

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

10 months ago

Cue Biopharma prioritizes autoimmune pipeline, axes a quarter of staff to save cash

10 months ago

ProMIS announces PIPE up to $122M; Confo raises €60M in Series B

10 months ago

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

10 months ago

Calliditas claims mid-stage win for rare liver disease drug

10 months ago

First page Previous page 125 126 127128129 130 131 Next page Last page